Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease
NCT: NCT06538311 · RECRUITING
Brief Summary
In this research study we want to learn more about the effects of non-invasive brain stimulation on memory and brain-network function in cognitively unimpaired older adults and in patients with amnestic mild cognitive impairment (aMCI). This study will use a form of non-invasive brain stimulation called repetitive Transcranial Magnetic Stimulation (rTMS). rTMS will slightly alter activity in an area of your brain that controls memory. Changes resulting from this stimulation will be measured with behavioral tests of memory and general cognition, as well as by taking images of your brain with Magnetic Resonance Imaging (MRI). Participants will come in for one baseline visit followed by 10 days of daily rTMS study visits (Monday through Friday) and an evaluation visit. Then, there will be a 2-week break. After this break, they will return for another baseline visit, an additional 10 days of rTMS, and a final evaluation visit.
Frequently Asked Questions
What is Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease?
Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease is a clinical trial registered under NCT06538311. Current status: RECRUITING.
What is the status of NCT06538311?
The current status of NCT06538311 (Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease) is: RECRUITING.
When did Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease start?
Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease started on 2023-05-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.